Verastem (VSTM) Assets (2011 - 2026)
Verastem's (VSTM) quarterly Assets came in at $227.8 million in Q1 2026, up 72.98% year-on-year from $131.7 million in Q1 2025, and down 7.56% quarter-over-quarter from $246.4 million in Q4 2025.
Verastem (VSTM) Assets (2011 - 2026) Analysis & Trends
Verastem's Assets history runs 16 years deep, the most recent figure standing at $227.8 million for Q1 2026.
- On a quarterly basis, Assets rose 72.98% year-over-year to $227.8 million in Q1 2026; TTM through Mar 2026 was $227.8 million, a 72.98% increase from a year earlier, with the FY2025 full-year figure at $246.4 million, up 142.71% from the prior year.
- Assets eased to $227.8 million in Q1 2026 per VSTM's latest filing, from $246.4 million in the prior quarter.
- Across five years, Assets topped out at $246.4 million in Q4 2025 and bottomed at $95.0 million in Q4 2022.
- The 5-year median for Assets is $126.4 million (2024), against an average of $146.9 million.
- Across the five-year window, Assets sank 44.85% in 2024 and surged 142.71% in 2025, its largest moves.
- Year by year, Assets stood at $95.0 million in 2022, then soared by 57.51% to $149.7 million in 2023, then plunged by 32.18% to $101.5 million in 2024, then jumped by 142.71% to $246.4 million in 2025, then fell by 7.56% to $227.8 million in 2026.
- Per Business Quant, the three latest VSTM Assets figures stand at $227.8 million (Q1 2026), $246.4 million (Q4 2025), and $176.9 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 311.58 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 78.88 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 8.55 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 39.68 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 26.48 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 40.87 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 811.27 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 10.03 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 2.25 Bn |
| 10 | Verastem | 166.09 Mn | -31.73 Mn | 15.90 Mn | 227.81 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 227.81 Mn |
| Dec 31, 2025 | 246.44 Mn |
| Sep 30, 2025 | 176.85 Mn |
| Jun 30, 2025 | 196.26 Mn |
| Mar 31, 2025 | 131.70 Mn |
| Dec 31, 2024 | 101.54 Mn |
| Sep 30, 2024 | 126.38 Mn |
| Jun 30, 2024 | 105.75 Mn |
| Mar 31, 2024 | 123.54 Mn |
| Dec 31, 2023 | 149.72 Mn |
| Sep 30, 2023 | 176.15 Mn |
| Jun 30, 2023 | 191.76 Mn |
| Mar 31, 2023 | 120.88 Mn |
| Dec 31, 2022 | 95.05 Mn |
| Sep 30, 2022 | 111.10 Mn |
| Jun 30, 2022 | 100.41 Mn |
| Mar 31, 2022 | 116.15 Mn |
| Dec 31, 2021 | 108.66 Mn |
| Sep 30, 2021 | 111.88 Mn |
| Jun 30, 2021 | 123.89 Mn |